Amyloid β peptide: from monomer solubility to fibril structure
(2021)- Abstract
- Alzheimer´s disease (AD) is the most common human neuro-degenerative disease characterized by the formation of cerebral plaques. Several are the amyloid-beta (Aβ) variants found in the brain of healthy individuals. Among them, the Aβ40 variant is predominantly found in the cerebrospinal fluid while the Aβ42 variant appears as fibrillar aggregates in the brain of AD patients. In vitro studies confirm that Aβ42 is more aggregation-prone than Aβ40; however, it is difficult to determine the solubility in a complex environment such as the human brain.
The propensity of Aβ fibrils to catalyze the formation of new aggregates via the interaction of soluble monomers with the fibril surface drives the attention towards Aβ fibril structures;... (More) - Alzheimer´s disease (AD) is the most common human neuro-degenerative disease characterized by the formation of cerebral plaques. Several are the amyloid-beta (Aβ) variants found in the brain of healthy individuals. Among them, the Aβ40 variant is predominantly found in the cerebrospinal fluid while the Aβ42 variant appears as fibrillar aggregates in the brain of AD patients. In vitro studies confirm that Aβ42 is more aggregation-prone than Aβ40; however, it is difficult to determine the solubility in a complex environment such as the human brain.
The propensity of Aβ fibrils to catalyze the formation of new aggregates via the interaction of soluble monomers with the fibril surface drives the attention towards Aβ fibril structures; however, a detailed model for these structures is lacking. This thesis presents the development of a bottom-up protocol for the in vitro detection of the solubility of Aβ40 peptide in pure buffer conditions, i.e. the concentration in solution at equilibrium. It is shown that by working with peptides that are recombinantly expressed in E. coli cells and purified to high homogeneity, the aggregation propensity of Aβ40 peptide can
be measured in vitro via systematic and reproducible solubility studies.
The second part of the thesis focuses on the investigation of the structures formed at the end state of fibril formation. A model calculation is here proposed for the determination of Aβ fibril shape, cross-section dimensions and most importantly, the number of filaments based on small angle scattering data. The relation between Aβ40 and 42 variants’ solubility concentrations and the high resolution structures of Aβ fibrils can help design experiments to elucidate the
factors that cause AD and provide a basis for the development of more effective treatments. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/e2407f9f-c887-44e9-b21c-affa1e7be1e4
- author
- Lattanzi, Veronica LU
- supervisor
-
- Sara Snogerup-Linse LU
- Ulf Olsson LU
- Emma Sparr LU
- opponent
-
- Associate professor Langkilde, Annette, Köpenhamns universitet
- organization
- publishing date
- 2021-11-08
- type
- Thesis
- publication status
- published
- subject
- keywords
- Alzheimer´s disease, Aβ solubility, small angle scattering, number of filaments, Aβ40, Aβ42 and Aβ42 S26Q , fibril structure
- pages
- 173 pages
- publisher
- Lund University
- defense location
- KC:C, Lund. Join via Zoom: https://lu-se.zoom.us/j/64585044841
- defense date
- 2021-12-17 13:00:00
- ISBN
- 978-91-7422-848-9
- 978-91-7422-849-6
- language
- English
- LU publication?
- yes
- id
- e2407f9f-c887-44e9-b21c-affa1e7be1e4
- date added to LUP
- 2021-11-23 16:22:25
- date last changed
- 2025-04-04 14:20:53
@phdthesis{e2407f9f-c887-44e9-b21c-affa1e7be1e4,
abstract = {{Alzheimer´s disease (AD) is the most common human neuro-degenerative disease characterized by the formation of cerebral plaques. Several are the amyloid-beta (Aβ) variants found in the brain of healthy individuals. Among them, the Aβ40 variant is predominantly found in the cerebrospinal fluid while the Aβ42 variant appears as fibrillar aggregates in the brain of AD patients. In vitro studies confirm that Aβ42 is more aggregation-prone than Aβ40; however, it is difficult to determine the solubility in a complex environment such as the human brain.<br/>The propensity of Aβ fibrils to catalyze the formation of new aggregates via the interaction of soluble monomers with the fibril surface drives the attention towards Aβ fibril structures; however, a detailed model for these structures is lacking. This thesis presents the development of a bottom-up protocol for the in vitro detection of the solubility of Aβ40 peptide in pure buffer conditions, i.e. the concentration in solution at equilibrium. It is shown that by working with peptides that are recombinantly expressed in E. coli cells and purified to high homogeneity, the aggregation propensity of Aβ40 peptide can<br/>be measured in vitro via systematic and reproducible solubility studies.<br/>The second part of the thesis focuses on the investigation of the structures formed at the end state of fibril formation. A model calculation is here proposed for the determination of Aβ fibril shape, cross-section dimensions and most importantly, the number of filaments based on small angle scattering data. The relation between Aβ40 and 42 variants’ solubility concentrations and the high resolution structures of Aβ fibrils can help design experiments to elucidate the<br/>factors that cause AD and provide a basis for the development of more effective treatments.}},
author = {{Lattanzi, Veronica}},
isbn = {{978-91-7422-848-9}},
keywords = {{Alzheimer´s disease; Aβ solubility; small angle scattering; number of filaments; Aβ40, Aβ42 and Aβ42 S26Q , fibril structure}},
language = {{eng}},
month = {{11}},
publisher = {{Lund University}},
school = {{Lund University}},
title = {{Amyloid β peptide: from monomer solubility to fibril structure}},
url = {{https://lup.lub.lu.se/search/files/110055837/V_Lattanzi_thesis_public.pdf}},
year = {{2021}},
}